150 Speakers Including:

Dirar Abdullah, Head, Adult Critical Care Services, Chair, Antibiotic Committee and Antibiotic Stewardship Program, Prime Hospital- Dubai

Dirar Abdullah at World Anti-Microbial Resistance Congress 2018

Brian Michael Aldridge, Clinical Professor, Department of Veterinary Clinical Medicine, University of Illinois College of Veterinary Medicine

Brian Michael Aldridge at World Anti-Microbial Resistance Congress 2018

Javad Aman, Chief Executive Officer, Integrated Biotherapeutics

Javad Aman at World Anti-Microbial Resistance Congress 2018

Thierry Bernardi, CEO, Biofilm Pharma

Susan Casey Bleasdale, Medical Director Infection Prevention & Control and Antimicrobial Stewardship, University of Illinois Hospital & Health Sciences System

Mark Bradley, Director, Proteus Venture Partners

Colin Broom, Chief Executive Officer, Nabriva Therapeutics

Manu Chaudhary, Joint Managing Director and Director of Research, Venus Remedies Ltd

Timothy Cooke, Chief Executive Officer, NovaDigm Therapeutics

Timothy Cooke at World Anti-Microbial Resistance Congress 2018

Sanjeet Dadwal, Associate Clinical Professor Head of Antimicrobial Stewardship Program, City of Hope

Sanjeet Dadwal at World Anti-Microbial Resistance Congress 2018

Glenn Dale, Head of Early Development, Antimicrobials, Polyphor Ltd

Glenn Dale at World Anti-Microbial Resistance Congress 2018

Gregory Daniel, Deputy Director, Duke University

Gregory Daniel at World Anti-Microbial Resistance Congress 2018

Lisa Davidson, Medical Director, Antimicrobial Support Network, Atrium Health

Kev Dhaliwal, Team Leader, Proteus Venture Partners

Kev Dhaliwal at World Anti-Microbial Resistance Congress 2018

Sarah Doernberg, Associate Professor, University of Southern California

Sarah Doernberg at World Anti-Microbial Resistance Congress 2018

Michael Dudley, Senior Vice President, Chief Scientific Officer, Head Infectious Disease Innovation, The Medicines Company

Barry Eisenstein, Chair, Scientific Advisory Board, CARB-X

Anthony Emeribe, Professor, University of Calibar, Nigeria and Member, WHO Strategic Advisory Group of Experts on In-Vitro Diagnostics (SAGE-IVD)

Anthony Emeribe at World Anti-Microbial Resistance Congress 2018

Greg Frank, Director, Infectious Disease Policy, B.I.O.

Greg Frank at World Anti-Microbial Resistance Congress 2018

Steven Gilman, Chief Executive Officer, Contrafect Corporation

Steven Gilman at World Anti-Microbial Resistance Congress 2018

Debra Goff, Infectious Diseases Specialist,The Ohio State University Wexner Medical Center Clinical Associate Professor, Ohio State University Medical Center

Rana Hamdy, Director, Antimicrobial Stewardship Program, Children's National Health System

Rana Hamdy at World Anti-Microbial Resistance Congress 2018

Benjamin Hammer, Co-leader of the Antimicrobial Stewardship Program, Children's National Health System

Benjamin Hammer at World Anti-Microbial Resistance Congress 2018

Elizabeth Hermsen, Head, Global Antimicrobial Stewardship, Merck & Co., Inc.

Silas Holland, Merck & Co

Silas Holland at World Anti-Microbial Resistance Congress 2018

Chris Houchens, Health Scientist, BARDA

David Huang, Chief Medical Officer, Motif Bio

David Huang at World Anti-Microbial Resistance Congress 2018

Dmitri Iarikov, Deputy Director in the Division of Anti-Infective Products, FDA

Dmitri Iarikov at World Anti-Microbial Resistance Congress 2018

Peter Jackson, CEO, The AMR Centre UK

Eugean Jiwanmall, Senior Research Analyst, Technology Evaluation & Medical Policy, Independence Blue Cross

Eugean Jiwanmall at World Anti-Microbial Resistance Congress 2018

Mark E. Jones, Head of Clinical Development and Preclinical Development, Basilea Pharmaceutica Ltd

Mark E. Jones at World Anti-Microbial Resistance Congress 2018

Lee Jones, Founder, President and Chief Executive Officer, Rebiotix, Inc.

Lee Jones at World Anti-Microbial Resistance Congress 2018

Sanjay Kakkar, CEO, Peptilogics

Patrick Keenan, Managing Director, Prevail Partners

Larry Kerr, Director, Office of Pandemic and Emerging Threats, Office of Global Affairs, Department of Health and Human Services

Barbara Kerstiens, Deputy Head of Unit, Fighting Infectious Diseases and Advancing Public Health Research and Innovatio, European Commission

Eili Klein, Fellow, Center for Disease Dynamics Economics & Policy

Daniel Knecht, Vice President, Clinical Strategy & Policy, Aetna

Jane Knisely, Program Officer, Bacteriology and Mycology Branch, NIAID, NIAID, NIH & University of Kansas

Jeremy Knox, Policy and Advocacy Lead, Drug-Resistant Infections Programme, Wellcome Trust

Jeremy Knox at World Anti-Microbial Resistance Congress 2018

Kerry LaPlante, Professor, University Of Rhode Island

Jill Massey, Senior Vice President, Medical Affairs, Melinta Therapeutics Inc

Tyler Merkeley, Program Manager, CARB-X

Mary Motyl, Director of Clinical Microbiology, Merck & Co

Steve Nagler, Executive Director, MedPro Investors LLC

Steve Nagler at World Anti-Microbial Resistance Congress 2018

Jean-Pierre Paccaud, Director, Business Development and Corporate Strategy, Global Antibiotic Research and Development Partnership (GARDP)

Jean-Pierre Paccaud at World Anti-Microbial Resistance Congress 2018

Brandon Palermo, CMO at ILUM Health Solutions and Executive Director and CMO, Merck & Co

Brandon Palermo at World Anti-Microbial Resistance Congress 2018

Rosanna Peeling, Director, International Diagnostics Centre and Chair and Professor of Diagnostic Research, London School of Hygiene and Tropical Medicine

Rosanna Peeling at World Anti-Microbial Resistance Congress 2018

Manos Perros, President & CEO, Entasis Therapeutics

Yannick Pletan, Acting Chief Medical Officer, Biofilm Pharma

Yannick Pletan at World Anti-Microbial Resistance Congress 2018

Joshua Resnick, Partner, SV Health Investors

Michael Salter, Innovation Scientist, A.B. Agri

Robert P Sambursky, Founder, President & Chief Technical/Medical Officer, Rapid Pathogen Screening, Inc (RPS)

Rangarajan Sampath, Chief Scientific Officer, FIND

Rangarajan Sampath at World Anti-Microbial Resistance Congress 2018

Tharini Sathiamoorthy, Vice President, AdvaMedDx

Monika Schneider, Research Associate, Margolis Center for Health Policy, Duke University

Ed Septimus, Medical Director of Infection Prevention and Epidemiology, H.C.A.

Ribhi Shawar, Branch Chief, Division of Microbiology, CDRH OIVD FDA

Rick Sibbel, Executive Director and Technical Services, Merck Animal Health

Tirsh Simner, Director of Bacteriology and Parasitology, Division of Medical Microbiology, Johns Hopkins Bayview Medical Center

Henry Skinner, Senior Vice President, Tekla Capital Management

Henry Skinner at World Anti-Microbial Resistance Congress 2018

Jeff Stein, President and Chief Executive Officer, Cidara Therapeutics

Jeff Stein at World Anti-Microbial Resistance Congress 2018

Leslie Tari, Vice President, Discovery, Cidara Therapeutics

Leslie Tari at World Anti-Microbial Resistance Congress 2018

Pamela Tenaerts, Executive Director, Clinical Trials Transformation Initiative

Pamela Tenaerts at World Anti-Microbial Resistance Congress 2018

Jennifer Townsend, Director of Antimicrobial Stewardship program, Johns Hopkins Bayview Medical Center

Ephraim Tsalik, Associate Professor of Medicine Division of Infectious Diseases, Duke University Medical Center

Ephraim Tsalik at World Anti-Microbial Resistance Congress 2018

Brian Tse, Health Scientist, HHS/BARDA

Marijn Verhoef, Engagement, Access To Medicine Foundation

Marijn Verhoef at World Anti-Microbial Resistance Congress 2018

David Visi, Senior Associate, Antibiotic Resistance Project, Pew Charitable Trusts

Daniel Wechsler, Chief Executive Officer, Melinta Therapeutics Inc

Blake Wise, Chief Executive Officer, Achaogen

Zachary Zimmerman, CEO, Forge Therapeutics

 

If you are interested in speaking at our 2018 conference, contact André Singer at +1 646 619 1797 or andre.singer@terrapinn.com now!

 

SIGN UP FOR EVENT UPDATES